Prevalence of Depression in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The aim of this study was to provide a summary estimate of depression prevalence among people with ankylosing spondylitis (AS) in comparison to those without AS. A systematic literature search was conducted using PubMed, Embase, PsycINFO, Web of Science, the Cochrane database library, China National Knowledge Infrastructure, and Wanfang Database from their inception to December 2016. The results showed that thirty-one eligible studies involving 8,106 patients were analyzed. Fifteen methods of defining depression were reported. The overall pooled prevalence of depression was 35% (95% CI, 28–43%), with high between-study heterogeneity (I2=98.8%, p<0.001). The relative risk of depression among people with AS was 1.76 (95% CI: 1.21–2.55, eight studies, n=3,006) compared with people without AS. The depression score [standardized mean difference (SMD)=0.43, 95% CI: 0.19–0.67, seven studies, n=549] was higher in AS patients than in controls. The main influence on depression prevalence was the sample size and country of origin. In conclusion, one-third of people with AS experience symptoms of depression. Depression was more prevalent in AS patients than in controls. Further research is needed to identify effective strategies for preventing and treating depression among AS patients.
Abstract
The aim of this study was to provide a summary estimate of depression prevalence among people with ankylosing spondylitis (AS) in comparison to those without AS. A systematic literature search was conducted using PubMed, Embase, PsycINFO, Web of Science, the Cochrane database library, China National Knowledge Infrastructure, and Wanfang Database from their inception to December 2016. The results showed that thirty-one eligible studies involving 8,106 patients were analyzed. Fifteen methods of defining depression were reported. The overall pooled prevalence of depression was 35% (95% CI, 28–43%), with high between-study heterogeneity (I2=98.8%, p<0.001). The relative risk of depression among people with AS was 1.76 (95% CI: 1.21–2.55, eight studies, n=3,006) compared with people without AS. The depression score [standardized mean difference (SMD)=0.43, 95% CI: 0.19–0.67, seven studies, n=549] was higher in AS patients than in controls. The main influence on depression prevalence was the sample size and country of origin. In conclusion, one-third of people with AS experience symptoms of depression. Depression was more prevalent in AS patients than in controls. Further research is needed to identify effective strategies for preventing and treating depression among AS patients.
참고문헌 (33)
- Braun J, "Ankylosing spondylitis", Lancet, 369, pp.1379~1390 (2007)
- Shen B, "Body image disturbance and quality of life in Chinese patients with ankylosing spondylitis", Psychol Psychother, 87, pp.324~337 (2014)
- Stubbs B, "Prevalence of depressive symptoms and anxiety in osteoarthritis : a systematic review and metaanalysis", Age Ageing, 45, pp.228~235 (2016)
- Mak A, "Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus", Clin Rheumatol, 30, pp.795~803 (2011)
- Zhang L, "The correlations of socioeconomic status, disease activity, quality of life, and depression", anxiety in Chinese patients with rheumatoid arthritis, 2017, pp.22, 28~36
- Liu Y, "The role of interleukin(IL)-17 in anxiety and depression of patients with rheumatoid arthritis", Int J Rheum Dis, 15, pp.183~187 (2012)
- Xu X, "Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis", Patient Prefer Adherence, 10, pp.879~885 (2016)
- Lépine JP, "The increasing burden of depression", Neuropsychiatr Dis Treat, 7, pp.3~7 (2011)
- Durmus D, "Psychiatric symptoms in ankylosing spondylitis : their relationship with disease activity, functional capacity, pain and fatigue", Compr Psychiatry, 62, pp.170~177 (2015)
- Batmaz I, "Sleep quality and associated factors in ankylosing spondylitis : relationship with disease parameters, psychological status and quality of life", Rheumatol Int, 33, pp.1039~1045 (2013)
- Brionez TF, "Psychological correlates of self-reported disease activity in ankylosing spondylitis", J Rheumatol, 37, pp.829~834 (2010)
- Gunaydin R, "Fatigue in patients with ankylosing spondylitis : relationships with disease-specific variables, depression, and sleep disturbance", Clin Rheumatol, 28, pp.1045~1051 (2009)
- Brionez TF, "Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis", Arthritis Res Ther, 11, pp.R182~ (2009)
- Aissaoui N, "Fatigue in patients with ankylosing spondylitis : prevalence and relationships with disease-specific variables, psychological status, and sleep disturbance", Rheumatol Int, 32, pp.2117~2124 (2012)
- Hakkou J, "Psychological status in Moroccan patients with ankylosing spondylitis and its relationships with disease parameters and quality of life", J Clin Rheumatol, 17, pp.424~428 (2011)
- Ho RC, "The effect of severity of depressive disorder on economic burden in a university hospital in Singapore", Expert Rev Pharmacoecon Outcomes Res, 13, pp.549~559 (2013)
- Shen CC, "Risk of psychiatric disorders following ankylosing spondylitis : a nationwide population-based retrospective cohort study", J Rheumatol, 43, pp.625~631 (2016)
- Dhakad U, "Sexual dysfunctions and lower urinary tract symptoms in ankylosing spondylitis", Int J Rheum Dis, 18, pp.866~872 (2015)
- Matcham F, "The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis", Rheumatology(Oxford), 52, pp.2136~2148 (2013)
- Zhang L, "Prevalence of depression and anxiety in systemic lupus erythematosus : a systematic review and meta-analysis", BMC Psychiatry, 17, pp.70~ (2017)
- Mak A, "Global trend of survival and damage of systemic lupus erythematosus : meta-analysis and meta-regression of observational studies from the 1950s to 2000s", Semin Arthritis Rheum, 41, pp.830~839 (2012)
- Mak A, "Early cerebral volume reductions and their associations with reduced lupus disease activity in patients with newly-diagnosed systemic lupus erythematosus", Sci Rep, 6, pp.22231~ (2016)
- Panic N, "Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses", PLoS One, 8, pp.e83138~ (2013)
- Mata DA, "Prevalence of depression and depressive symptoms among resident physicians : a systematic review and meta-analysis", JAMA, 314, pp.2373~2383 (2015)
- Borenstein M, "A basic introduction to fixed-effect and random-effects models for meta-analysis", Res Synth Methods, 1, pp.97~111 (2010)
- Cheung MW, "Conducting a meta-analysis : basics and good practices", Int J Rheum Dis, 15, pp.129~135 (2012)
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Sterne JA, "Funnel plots for detecting bias in meta-analysis : guidelines on choice of axis", J Clin Epidemiol, 54, pp.1046~1055 (2001)
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Lu Y, "Prevalence of anxiety and depressive symptoms in adolescents with asthma : a metaanalysis and meta-regression", Pediatr Allergy Immunol, 23, pp.707~715 (2012)
- Zhang MW, "Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease : a systematic review, meta-analysis and meta-regression", Gen Hosp Psychiatry, 33, pp.217~223 (2011)
- Ho RC, "Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis", Int J Rheum Dis, 14, pp.37~47 (2011)
- Hotopf M, "Depression in advanced disease: a systematic review Part 1. Prevalence and case finding", Palliat Med, 16, pp.81~97 (2002)